1. Clinical spectrum of Lyme disease.
- Author
-
Cardenas-de la Garza JA, De la Cruz-Valadez E, Ocampo-Candiani J, and Welsh O
- Subjects
- Animals, Anti-Bacterial Agents therapeutic use, Borrelia burgdorferi Group classification, Borrelia burgdorferi Group drug effects, Clinical Laboratory Techniques, Humans, Ixodes classification, Ixodes microbiology, Prognosis, Treatment Outcome, Borrelia burgdorferi Group physiology, Lyme Disease diagnosis, Lyme Disease drug therapy, Lyme Disease pathology, Lyme Disease physiopathology, Skin Diseases, Bacterial diagnosis, Skin Diseases, Bacterial drug therapy, Skin Diseases, Bacterial pathology, Skin Diseases, Bacterial physiopathology
- Abstract
Lyme disease (borreliosis) is one of the most common vector-borne diseases worldwide. Its incidence and geographic expansion has been steadily increasing in the last decades. Lyme disease is caused by Borrelia burgdorferi sensu lato, a heterogeneous group of which three genospecies have been systematically associated to Lyme disease: B. burgdorferi sensu stricto Borrelia afzelii and Borrelia garinii. Geographical distribution and clinical manifestations vary according to the species involved. Lyme disease clinical manifestations may be divided into three stages. Early localized stage is characterized by erythema migrans in the tick bite site. Early disseminated stage may present multiple erythema migrans lesions, borrelial lymphocytoma, lyme neuroborreliosis, carditis, or arthritis. The late disseminated stage manifests with acordermatitis chronica atrophicans, lyme arthritis, and neurological symptoms. Diagnosis is challenging due to the varied clinical manifestations it may present and usually involves a two-step serological approach. In the current review, we present a thorough revision of the clinical manifestations Lyme disease may present. Additionally, history, microbiology, diagnosis, post-treatment Lyme disease syndrome, treatment, and prognosis are discussed.
- Published
- 2019
- Full Text
- View/download PDF